Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process. This segment's products are used in various applications comprising asphalt paving, oilfield exploration and production, printing inks, adhesives, agrochemical dispersants, lubricants, and other diverse industries. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
Current SymbolNYSE:NGVT
Previous SymbolNASDAQ:NGVT
CUSIPN/A
Phone843-740-2300
Debt
Debt-to-Equity Ratio2.31
Current Ratio2.34
Quick Ratio1.26
Price-To-Earnings
Trailing P/E Ratio37.72
Forward P/E Ratio25.68
P/E Growth2.17
Sales & Book Value
Annual Sales$972.40 million
Price / Sales4.20
Cash Flow$3.5248 per share
Price / Cash27.61
Book Value$7.69 per share
Price / Book12.66
Profitability
EPS (Most Recent Fiscal Year)$2.58
Net Income$126.50 million
Net Margins15.53%
Return on Equity47.45%
Return on Assets12.51%
Miscellaneous
Employees1,500
Outstanding Shares41,970,000
Market Cap$4.14 billion
OptionableOptionable
Ingevity (NYSE:NGVT) Frequently Asked Questions
What is Ingevity's stock symbol?
Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."
How were Ingevity's earnings last quarter?
Ingevity Corp (NYSE:NGVT) issued its earnings results on Wednesday, October, 24th. The company reported $1.16 EPS for the quarter, beating the Zacks' consensus estimate of $1.04 by $0.12. The business earned $311.20 million during the quarter, compared to analysts' expectations of $305.50 million. Ingevity had a net margin of 15.53% and a return on equity of 47.45%. View Ingevity's Earnings History.
When is Ingevity's next earnings date?
What price target have analysts set for NGVT?
8 equities research analysts have issued 1-year price objectives for Ingevity's shares. Their forecasts range from $90.00 to $110.00. On average, they expect Ingevity's share price to reach $100.25 in the next year. This suggests a possible upside of 2.2% from the stock's current price. View Analyst Price Targets for Ingevity.
What is the consensus analysts' recommendation for Ingevity?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity.
Has Ingevity been receiving favorable news coverage?
News stories about NGVT stock have been trending negative on Monday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ingevity earned a media sentiment score of -2.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days.
Who are some of Ingevity's key competitors?
Some companies that are related to Ingevity include Koninklijke DSM (RDSMY), ASAHI KASEI Cor/ADR (AHKSY), FMC (FMC), Johnson Matthey (JMPLY), Chemours (CC), Huntsman (HUN), Ashland Global (ASH), KURARAY Co Ltd/ADR (KURRY), W. R. Grace & Co (GRA), Olin (OLN), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP) and Innospec (IOSP).
Who are Ingevity's key executives?
Ingevity's management team includes the folowing people:
- Mr. D. Michael Wilson, Pres, CEO & Director (Age 55)
- Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 51)
- Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 60)
- Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 52)
- Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 57)
Who are Ingevity's major shareholders?
Ingevity's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.52%), FMR LLC (2.06%), Wells Fargo & Company MN (1.85%), Bank of New York Mellon Corp (1.56%), Massachusetts Financial Services Co. MA (1.56%) and Alliancebernstein L.P. (1.33%). View Institutional Ownership Trends for Ingevity.
Which major investors are selling Ingevity stock?
NGVT stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Patten & Patten Inc. TN, American Century Companies Inc., Prudential Financial Inc., WINTON GROUP Ltd, Ardevora Asset Management LLP, JPMorgan Chase & Co. and Strs Ohio. View Insider Buying and Selling for Ingevity.
Which major investors are buying Ingevity stock?
NGVT stock was acquired by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, BlackRock Inc., Eagle Asset Management Inc., EAM Investors LLC, Chartwell Investment Partners LLC, Rice Hall James & Associates LLC, Columbus Circle Investors and Bank of New York Mellon Corp. View Insider Buying and Selling for Ingevity.
How do I buy shares of Ingevity?
Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ingevity's stock price today?
One share of NGVT stock can currently be purchased for approximately $98.10.
How big of a company is Ingevity?
Ingevity has a market capitalization of $4.14 billion and generates $972.40 million in revenue each year. The company earns $126.50 million in net income (profit) each year or $2.58 on an earnings per share basis. Ingevity employs 1,500 workers across the globe.
What is Ingevity's official website?
How can I contact Ingevity?
Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]
MarketBeat Community Rating for Ingevity (NYSE NGVT)
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
